CD207阳性树突细胞通过CD8+ T细胞通路促进肺瘤 在慢性阻塞性肺病中
Shurui Xuan1,2, Yunhui Wu1, Feng Liu3
1Department of Respiratory & Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|January 7, 2026
概括
CD207阳性树突细胞 (CD207+DCs) 在慢性阻塞性肺病 (COPD) 中驱动肺气进展. 准这些细胞可以为肺管理提供一种新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
背景情况:
- 肺,慢性阻塞性肺病 (COPD) 的一个组成部分,提出了重要的管理挑战.
- CD207阳性树突细胞 (CD207+ DCs) 越来越多地被认为是免疫反应中的作用.
研究的目的:
- 为了研究CD207+DCs在肺的发病过程中的作用.
- 为了确定CD207+DCs作为潜在的治疗瘤的目标.
主要方法:
- 在COPD患者中,CD207+ DC丰度与肺重度和肺功能之间的相关性分析.
- 在小鼠肺瘤模型中,CD207+ DCs的收养转移实验.
- 调查 CD207+ DC 扩张和激活背后的机制.
主要成果:
- 慢性肺炎患者小气道中CD207+ DCs的丰度增加与肺的严重程度和肺功能降低相关 (FEV1%前).
- 在CD207+绝杀小鼠中,CD207+ DCs的收养转移加剧了肺气,炎症和CD8+T细胞反应.
- 香烟烟雾引起的GM-CSF驱动CD207+DC扩张,然后通过MHC-I交叉呈现促进CD8+T细胞反应.
结论:
- CD207+ DCs通过调节致病性 CD8+ T 细胞反应,是肺瘤进展的关键调解者.
- CD207+ DCs是治疗COPD肺气的一个有前途的治疗标.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
01:22Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
01:20COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K
01:24T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K